oh right. I thought you were talking about value of life. You’re not now.
Just to recap a bit. My argument is that for Covid, MSB Isn’t cost effective. There are better cheaper alternatives. Maybe, if the MSB treatment actually proven to work, then I can understand a market case for cancer because there you can target a serious affliction. With Covid you can’t because you need to treat early and so cannot target (and if you wait, the product dose not work).
You were the one who brought up the old chestnut much seen by cheerleading posters of “oh what about the value of human life”. I simply answered this and so I will post where I like. The other one I see all the time is “oh what about the kiddies” when bemoaning the FDA rejection.
It is a wildly expensive product. It is simply not cost effective to treat loads of people who are likely to recover without being treated.
oh right. I thought you were talking about value of life. You’re...
-
- There are more pages in this discussion • 10,010 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |